GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Cash & Current Investments (2009 - 2026)

Updated

Gsk (GSK) reported Cash & Current Investments of $4.29 billion for the quarter ended Jun 30, 2026, down 10.7% from $4.8 billion a year earlier and down 9.8% from the prior quarter.

Analysis

Gsk (GSK) Cash & Current Investments (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk posted Cash & Current Investments of $4.64 billion, down 8.8% from the prior year.

  • Cash & Current Investments has a five-year compound annual growth rate of -10.9% (years ended Dec 2020 to Dec 2025).
  • By year, Cash & Current Investments came in at $5.09 billion in the year ended Dec 31, 2024 (+33.4%), $3.81 billion in the year ended Dec 31, 2023 (-18.7%), $4.69 billion in the year ended Dec 31, 2022 (-23.6%) and $6.14 billion in the year ended Dec 31, 2021 (-25.8%).
  • The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Cash & Current Investments since the quarter ended Sep 30, 2024.
  • Year over year, Cash & Current Investments has now declined in each of the last three quarters, with growth averaging 12.2% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was the quarter ended Mar 31, 2023 (growth of 554.5%); the low point was the quarter ended Mar 31, 2022 (a decline of 92.2%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $4.76 billion (quarter ended Mar 31, 2026), $4.68 billion (quarter ended Dec 31, 2025) and $4.45 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 20.76 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 6.57 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 4.89 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 3.18 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 11.70 Bn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn 4.17 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.17 Bn
Mar 31, 2026 4.64 Bn
Dec 31, 2025 4.53 Bn
Sep 30, 2025 4.46 Bn
Jun 30, 2025 4.83 Bn
Mar 31, 2025 5.65 Bn
Dec 31, 2024 4.99 Bn
Sep 30, 2024 4.17 Bn
Jun 30, 2024 3.77 Bn
Mar 31, 2024 3.57 Bn
Dec 31, 2023 3.70 Bn
Sep 30, 2023 4.11 Bn
Jun 30, 2023 4.07 Bn
Mar 31, 2023 3.59 Bn
Dec 31, 2022 4.45 Bn
Sep 30, 2022 4.34 Bn
Jun 30, 2022 8.23 Bn
Mar 31, 2022 513.92 Mn
Dec 31, 2021 5.84 Bn
Sep 30, 2021 4.84 Bn
API Access

Gsk Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GSK&period=max&api_key=YOUR_API_KEY